Foundation Medicine to Present New Data on its Comprehensive Cancer Genomic Test at American Society of Clinical Oncology 2011 Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc., a cancer diagnostics company that aims to bring comprehensive cancer genome analysis to routine care, today announced that it will present new data from its next-generation sequencing (NGS) based testing platform, at the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 3-7, 2011, at McCormick Place in Chicago.

MORE ON THIS TOPIC